Andrew Hanna, MD
-
Specialty: Surgical Oncology
View Expertise -
Primary Location: 11100 Euclid Ave (0 mi.)
Other Locations - Languages Spoken: Arabic, English
Office Locations
UH Cleveland Medical Center Bolwell (0 mi.)
11100 Euclid Ave
Bolwell Ste 2100
Cleveland, OH 44106
UH Seidman Cancer Center (0 mi.)
11100 Euclid Ave
1st Floor
Cleveland, OH 44106
216-844-7874
UH Parma Medical Arts Building 4 (11 mi.)
6115 Powers Blvd
Medical Arts Cntr 4 Ste 303
Parma, OH 44129
440-446-8600
UH Broadview Hts Health Center (13 mi.)
5901 E Royalton Rd
Ste 2300
Broadview Heights, OH 44147
440-792-9040
University Hospitals (18 mi.)
29099 Health Campus Dr
Bldg 3 Ste 250
Westlake, OH 44145
440-446-8600
UH Fairlawn Health Center (25 mi.)
3800 Embassy Pkwy
Ste 250
Fairlawn, OH 44333
330-664-8160
Biography: Andrew Hanna, MD
Expertise
Titles
- Assistant Professor, CWRU School of Medicine
Certifications & Memberships
- Surgery - American Board of Surgery
Education
Fellowship | Surgical Oncology
Surgical Oncology - Memorial Sloan-Kettering Cancer Center (2023 - 2025)
Research Fellowship | Surgical Oncology
Surgical Oncology - Hospital Of The University Of Pennsylvania (2019 - 2021)
Residency | General Surgery
General Surgery - Hospital Of The University Of Pennsylvania (2016 - 2023)
Medical Education
University Of Maryland School Of Medicine (2012 - 2016)
Undergraduate
Johns Hopkins University (2012)
About
Andrew Hanna, MD, is a surgical oncologist who joined University Hospitals Seidman Cancer Center in 2025.
Dr. Hanna attended Johns Hopkins University (Baltimore, Maryland), where he earned a Bachelor of Arts in neuroscience and a Bachelor of Arts in economics in 2012. He earned his medical degree at the University of Maryland School of Medicine (Baltimore, Maryland) in 2016. Dr. Hanna completed his general surgery residency from 2016 to 2023 at the University of Pennsylvania (Philadelphia, Pennsylvania), which included a two-year postdoctoral research fellowship in the cancer laboratory of Dr. Ronald DeMatteo. He then completed a fellowship in surgical oncology at Memorial Sloan Kettering Cancer Center (New York, New York) from 2023 to 2025.
Among other honors and awards, Dr. Hanna was named the 2025 Kristen Ann Carr Fund Surgical Fellow and was the recipient of the 2024 Dr. Murray F. Brennan/Gorin Fellowship Endowment, both as a fellow at Memorial Sloan Kettering Cancer Center (2023-2025). During residency he was Editor-in-Chief of the Penn Evidence Based Literature Review (2020-2021) and served as the Resident Executive Council Chair (2020-2021) in the Department of Surgery, University of Pennsylvania. As a medical student at the University of Maryland, he was awarded the Wayne W. Babcock Award for Excellence in Surgery (2016).
Dr. Hanna has contributed surgical oncology research to such peer-reviewed medical publications as Annals of Surgical Oncology, Cancer Immunology Research, JAMA Network Open, Journal of Surgical Education, Journal of the American Academy of Dermatology, Journal of the American College of Surgeons, Journal of Neuro-Oncology and Journal of Visualized Experiments. As an regularly invited speaker and presenter, Dr. Hanna has delivered oral and poster presentations at meetings of the American Association for Cancer Research, American Surgical Congress, Connective Tissue Oncology Society, Society of Surgical Oncology and Society of Thoracic Surgeons, among others.
Research & Publications
Research Links
PubMed
View Research
Research Interests
Genomics, next-generation sequencing, computational biology, sarcoma tumor heterogeneity, tumor immune response, defining sarcoma subtypes, DNA/RNA-level functional tumor analysis
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Andrew Hanna did not disclose any Outside Relationships with Industry.